Slower dose titration schedules may be considered for patients with significant symptoms, allowing more time for adaptation at each dose level before escalation
Most adverse events with semaglutide treatment were mild or moderate
are planning surgery or other procedure that uses anesthesia or deep sedation
Does Semaglutide Appear on Standard Blood Tests
When comparing semaglutide specifically against other diabetes and obesity drugs including Farxiga, metformin, and orlistat the reseachers again saw a higher rate of suicidal ideation reported for semaglutide, according to the study, published Tuesday in JAMA Network Open
These approaches have led to significant weight loss with the dual GLP-1/glucagon receptor agonist survodutide (-13.5% with the 6-mg dose at 76 weeks in a phase 3 SYNCHRONIZE-1 trial) [16] , the dual GLP-1 receptor agonist and GIP antagonist Maridebart cafraglutide (known as MariTide) (-12.3% to -16.2% across different doses at 52 weeks in a phase 2 trial) [17] or the triple GLP-1/GIP/glucagon receptor agonist retatrutide (-24.2% with the 12-mg dose at 48 weeks in a phase 2 trial) [18]